ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is SymBio Pharmaceuticals Ltd. ?
1
The company has declared negative results for the last 14 consecutive quarters
- The company has declared negative results in Dec 22 after 7 consecutive negative quarters
- ROCE(HY) Lowest at -322.67%
- INTEREST(Q) At JPY 16.63 MM has Grown at 43.71%
- CASH AND EQV(HY) Lowest at JPY 4,781.43 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -60.80%, its profits have fallen by -26.5%
3
Below par performance in long term as well as near term
- Along with generating -60.80% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is SymBio Pharmaceuticals Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
SymBio Pharmaceuticals Ltd.
-60.8%
-0.46
124.18%
Japan Nikkei 225
88.41%
3.25
27.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-15.23%
EBIT Growth (5y)
0.29%
EBIT to Interest (avg)
-451.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.86
Sales to Capital Employed (avg)
0.60
Tax Ratio
0.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.63%
ROE (avg)
9.20%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.53
EV to EBIT
-1.38
EV to EBITDA
-1.38
EV to Capital Employed
16.52
EV to Sales
4.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1196.83%
ROE (Latest)
-369.47%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET PROFIT(HY)
Higher at JPY -3,540.4 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -375.69 %
DEBTORS TURNOVER RATIO(HY)
Highest at 6.31 times
-35What is not working for the Company
ROCE(HY)
Lowest at -322.67%
INTEREST(Q)
At JPY 16.63 MM has Grown at 43.71%
CASH AND EQV(HY)
Lowest at JPY 4,781.43 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.63 times
NET SALES(Q)
Lowest at JPY 233.46 MM
OPERATING PROFIT(Q)
Lowest at JPY -2,341.11 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -1,002.78 %
PRE-TAX PROFIT(Q)
Lowest at JPY -2,390.61 MM
NET PROFIT(Q)
Lowest at JPY -2,404.58 MM
EPS(Q)
Lowest at JPY -35.89
Here's what is working for SymBio Pharmaceuticals Ltd.
Debt-Equity Ratio
Lowest at -375.69 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 6.31 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for SymBio Pharmaceuticals Ltd.
Net Sales
At JPY 233.46 MM has Fallen at -28.59%
over average net sales of the previous four periods of JPY 326.91 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (JPY MM)
Pre-Tax Profit
At JPY -2,390.61 MM has Fallen at -104.66%
over average net sales of the previous four periods of JPY -1,168.07 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (JPY MM)
Net Profit
At JPY -2,404.58 MM has Fallen at -104.65%
over average net sales of the previous four periods of JPY -1,174.96 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (JPY MM)
Interest
At JPY 16.63 MM has Grown at 43.71%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Net Sales
Lowest at JPY 233.46 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (JPY MM)
Operating Profit
Lowest at JPY -2,341.11 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (JPY MM)
Operating Profit Margin
Lowest at -1,002.78 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at JPY -2,390.61 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (JPY MM)
Net Profit
Lowest at JPY -2,404.58 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
EPS
Lowest at JPY -35.89
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (JPY)
Cash and Eqv
Lowest at JPY 4,781.43 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 1.63 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
